SCHEMBL10747356

SCHEMBL10747356

S=c1c2ccccc2[se]n1-c1nc2ccccc2[nH]1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ AURKA O14965 3/20 0.44
▸ BCHE P06276 2/20 0.44
▸ ACHE P22303 2/20 0.44
▸ RAB9A P51151 4/20 0.44
▸ KDM4E B2RXH2 4/20 0.44
▸ NPC1 O15118 3/20 0.44
▸ PAX8 Q06710 2/20 0.44
▸ HTR3A P46098 1/20 0.43
▸ PKM P14618 2/20 0.43
▸ SMN1; SMN2 Q16637 2/20 0.43
▸ MEN1 O00255 2/20 0.43
▸ KMT2A Q03164 2/20 0.43
▸ HSP90AA1 P07900 1/20 0.43
▸ TP53 P04637 2/20 0.42
▸ ALKBH3 Q96Q83 2/20 0.42
▸ TRPC3 Q13507 1/20 0.40
▸ ALDH1A1 P00352 2/20 0.40
▸ ABCB11 O95342 1/20 0.40
▸ NPSR1 Q6W5P4 1/20 0.40
▸ HSD17B10 Q99714 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10747528 0.82 MAPK8 (0.41) AURKARAB9AKDM4ENPC1MEN1
SCHEMBL5916780 0.82 KDM4E (0.53) AURKABCHEACHERAB9AKDM4E
SCHEMBL10749211 0.75 METAP2 (0.35) BCHEACHEKDM4EPKMMEN1
SCHEMBL10747549 0.72 METAP2 (0.35) BCHEACHEKDM4EPKMMEN1
SCHEMBL10747112 0.70 HRH3 (0.40) BCHEACHERAB9AKDM4ENPC1
SCHEMBL10748283 0.70 METAP2 (0.36) BCHEACHEKDM4EPKMMEN1
SCHEMBL10501589 0.69 METAP2 (0.61) BCHEACHEKDM4EPKMMEN1
SCHEMBL20040367 0.68 AURKA (0.69) AURKABCHEACHERAB9AKDM4E
SCHEMBL10747582 0.68 METAP2 (0.40) BCHEACHEKDM4EPKMMEN1
SCHEMBL10502470 0.67 METAP2 (0.46) BCHEACHEKDM4EPKMMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4711961-A Benzisoselenazolethiones and process for the treatment of various diseases in humans A. NATTERMANN & CIE GMBH (DE) 1987-12-08 — — US disclosed
EP-0154851-A1 Benzisoselenazolethiones,process for their preparation and pharmaceutical products containing these compounds A. Nattermann & Cie. GmbH (DE) 1985-09-18 — — EP disclosed
Send feedback